Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

A Retrospective Multicenter Study to Determine 5-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-01 Study

Study:

A Retrospective Multicenter Study to Determine 5-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-01 Study (CTOT-17)

Rationale:

n/a

Purpose:

This study is a multicenter, non-randomized, retrospective study to collect long term (5 years post-transplant) clinical outcome data to test whether the results of the noninvasive immune monitoring test strategy performed in the parent study (CTOT-01, NCT00308802) in first six-month post-transplant is predictive of 5-year outcomes. Each center will complete a retrospective chart review for the data on patient survival, graft survival and renal function.

Study Status: Enrolling by invitation

Recruiting:
n/a

Condition Intervention Phase
Kidney Disease
Kidney Failure
End Stage Renal Disease
n/a N/A

Verified by National Institute of Allergy and Infectious Diseases (NIAID) November, 2013

Sponsored by: National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by: National Institute of Allergy and Infectious Diseases (NIAID)
ClinicalTrials.gov identifier: NCT01974999

Study Type: Interventional

Study Design: Observational Model: Cohort, Time Perspective: Retrospective

Cleveland Clinic Foundation, Glickman Urological Institute
Cleveland, Ohio 44195
United States

Peter S Heeger, MD., Principal Investigator
Donald E Hricik, MD., Study Chair

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site